ӢQ:N-PROPIONYL-(4S,5R)-4-METHYL-5-PHENYL-2-OXAZOLIDINONEӢͬx~:(4R,5S)-4-METHYL-5-PHENYL-3-PROPIONYL-2-OXAZOLIDINONE;N-PROPIONYL-(4R,5S)-4-METHYL-5-PHENYL-2-OXAZOLIDINONE
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0098493 | 100mg |
1
|
ԃr(ji) |
Q-0098493 | 250mg |
1
|
ԃr(ji) |
Q-0098493 | 500mg |
1
|
ԃr(ji) |
Q-0098493 | 1g |
1
|
ԃr(ji) |
Q-0098493 | 5g |
1
|
ԃr(ji) |

(4R,5S)-3--4--5--2-fͪQ
(4R,5S)-3--4--5--2-fͪ
Ӣ (4R,5S)-4-Methyl-5-phenyl-3-propionyl-2-oxazolidinone
Ąe (4R,5S)-4--5--3--2-fͪ
(4R,5S)-3--4--5--2-fͪW(xu)|(zh)
ܶ 1.161 g/mL at 20ºC(lit.)
c(din) 394.4ºC at 760 mmHg
ʽ C13H15NO3
233.26300
Wc(din) 192.3ºC
|(zh) 233.10500
PSA 46.61000
LogP 2.44290
n20/D 1.530
(ch)l 2-8°C
;
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:N,N-DIMETHYLTRIFLUOROACETAMIDEӢͬx~:2,2,2-Trifluoro-N,N-dimethylacetamide;TIMTEC-BBSBB008188;N,N-DIMETHYLTRIFLUOROACETAMIDE;2,2,2-TRIFLUORO-N,N-DIMETHYLACETAMIDE
-
ӢQ:SODIUM BORODEUTERIDEӢͬx~:Sodium borodeuteride, 98 atom% d, for NMR;Sodium borodeuteride, for NMR CAS̖(ho):15681-89-7